News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘Genetics’ clear

  • Researchers at Dana-Farber have developed a tool to help predict how a patient’s tumor is likely to behave and which of several possible treatments is most likely to be effective.

Tags: BreastCancer, Genetics

  • The most comprehensive genetic study to date of the blood cancer multiple myeloma has revealed that the genetic landscape of the disease may be more complicated than previously thought.

Tags: BasicResearch, MultipleMyeloma, Genetics

  • Dana-Farber researchers identify a specific mutation that switches on Waldenström's Macroglobulinemia in one-third of patients, and a drug that targets the mutation — which could lead to better treatments for those patients.

Tags: Genetics, Lymphoma

  • Dana-Farber/Boston Children's researchers reported promising outcomes data for the first group of boys with X-linked severe combined immunodeficiency syndrome (SCID-X1), a fatal genetic immunodeficiency also known as "bubble boy" disease, who were treated in an international clinical study of a new form of gene therapy.

Tags: ChildhoodCancer, ImmuneSystem, Genetics, Leukemia

  • The Joint Center for Cancer Precision Medicine, a collaborative initiative among Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Boston Children’s Hospital, and the Broad Institute of MIT and Harvard, has been established to create “precision medicine treatment pathways” for patients with advanced cancers and to speed the development of personalized therapies.

Tags: Genomics, Partnerships, TargetedTherapy, Genetics

  • Dana-Farber's Judy Garber, MD, MPH, an internationally recognized leader in clinical and translational research on breast cancer, has been elected to the Institute of Medicine.

Tags: BreastCancer, Honors, Genetics

  • Research led by Dana-Farber/Boston Children's Cancer and Blood Disorders Center reports the discovery of a new genetic target for potential therapy of sickle cell disease.

Tags: BasicResearch, Genetics

  • Dana-Farber researchers have used a novel combination of two oral targeted drugs to dramatically slow the growth of glioblastoma brain tumors in mice, which significantly extended the animals’ survival.

Tags: Genetics, BrainTumors

  • Levi Garraway, MD, PhD, has been named as a recipient of the prestigious Paul Marks Prize for Cancer Research, which recognizes promising investigators aged 45 or younger who are advancing the field of cancer research.

Tags: Genomics, Honors, Genetics

  • Scanning the DNA of nearly 5,000 tumor samples, a team led by scientists at Dana-Farber Cancer Institute and the Broad Institute has identified 140 regions of scrambled genetic code believed to contain many undiscovered cancer genes.

Tags: Genomics, Genetics

Showing 1-10 of 32 items